-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UFQJQZKZRIpGjzYJHLEyiH1XooLSi4CAHv1IEt+v6BXOyB1N9l8FzJOJnbKtHimb CQ7/HDZDc01rrFeWhkRclQ== 0000905081-01-500002.txt : 20020410 0000905081-01-500002.hdr.sgml : 20020410 ACCESSION NUMBER: 0000905081-01-500002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20011031 FILED AS OF DATE: 20011108 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MIRAVANT MEDICAL TECHNOLOGIES CENTRAL INDEX KEY: 0000933745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770222872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25544 FILM NUMBER: 1778343 BUSINESS ADDRESS: STREET 1: 336 BOLLAY DRIVE CITY: SANTA BARBARA STATE: CA ZIP: 93117 BUSINESS PHONE: 8056859880 MAIL ADDRESS: STREET 1: 336 BOLLAY DRIVE CITY: SANTA BARBARA STATE: CA ZIP: 93117 FORMER COMPANY: FORMER CONFORMED NAME: PDT INC /DE/ DATE OF NAME CHANGE: 19941214 COMPANY DATA: COMPANY CONFORMED NAME: SHACKNAI JONAH CENTRAL INDEX KEY: 0000905081 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR IRS NUMBER: 091462383 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 8125 N HAYDEN RD CITY: SCOTTSDALE STATE: AZ ZIP: 85258 BUSINESS PHONE: 6028088800 MAIL ADDRESS: STREET 1: 8125 N HAYDEN RD CITY: SCOTTSDALE STATE: AZ ZIP: 85258 4 1 shacknaif4nov01.txt FORM 4 CHANGE IN BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. 1. Name and Address of Reporting Person(s) Jonah Shacknai 8125 N. Hayden Road Scottsdale, AZ 85258 2. Issuer Name and Ticker or Trading Symbol Miravant Medical Technologies (MRVT) 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) 4. Statement for Month/Year 10/01 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [X] Director [ ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [ ] Form filed by More than One Reporting Person
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of action action or Disposed of (D) Securities Indirect Date Code A Beneficially D Beneficial (Month/ or Owned at or Ownership Day/Year) Code V Amount D Price End of Month I - ------------------------------------------------------------------------------------------------------------------------------------ Table II (PART 1) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6) - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and Security or Exercise action action Securities Acquired (A) Expiration Date Price of Date Code or Disposed of (D) Derivative Security Code V A D Exercisable Expiration - ------------------------------------------------------------------------------------------------------------------------------------ Non-Qualified Stock Option $7.5000 10/01/01 (1) A 7,500 10/01/01 10/01/11 (right to buy) Non-Qualified Stock Option $7.5000 10/01/01 (2) J 7,500 10/01/01 10/01/11 (right to buy) Table II (PART 2) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11) - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of Security action of Underlying of Deri- Derivative Indirect Date Securities vative Securities D Beneficial Amount or Security Beneficially or Ownership Number of Owned at I - Title Shares End of Month - ------------------------------------------------------------------------------------------------------------------------------------ Non-Qualified Stock Option 10/01/01 Common Stock 7,500 $7.5000 D Direct (right to buy) (1) Non-Qualified Stock Option 10/01/01 Common Stock 7,500 $7.5000 0 D Direct (right to buy) (2) Explanation of Responses: (1) Automatic grant to outside director in consideration of service as board member. (2) Options were transferred to a trust administered by an independent trustee for the benefit of Mr. Shacknai's children for which Mr. Shacknai has no voting power. Thus, Mr. Shacknai disclaims beneficial ownership.
SIGNATURE OF REPORTING PERSON /S/ Jonah Shacknai - ------------------ Jonah Shacknai DATE 10/23/01
-----END PRIVACY-ENHANCED MESSAGE-----